4-methoxyamphetamine has been researched along with Panic Disorder in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choe, AY; Choi, TK; Kim, B; Lee, JE; Lee, JY; Lee, KS; Lee, SH | 1 |
| Chelminski, I; Dalrymple, K; Ellison, WD; Gazarian, D; Multach, MD; Zimmerman, M | 1 |
| Gash, A; Udo, I | 1 |
| Conti, S; Fava, GA; Grandi, S; Rafanelli, C; Savron, G | 1 |
4 other study(ies) available for 4-methoxyamphetamine and Panic Disorder
| Article | Year |
|---|---|
Serotonergic genes (5-HTT and HTR1A) and separation life events: gene-by-environment interaction for panic disorder.
Topics: Adolescent; Adult; Aged; Asian People; Case-Control Studies; Death; Divorce; Endophenotypes; Female; Gene-Environment Interaction; Genetic Predisposition to Disease; Genotype; Humans; Life Change Events; Male; Middle Aged; Panic Disorder; Personality Inventory; Polymorphism, Genetic; Receptor, Serotonin, 5-HT1A; Serotonin Plasma Membrane Transport Proteins | 2013 |
Does 'fear of dying' indicate a more severe presentation of panic disorder?
Topics: Adult; Cognition; Death; Fear; Female; Humans; Male; Middle Aged; Panic Disorder; Severity of Illness Index; Symptom Assessment | 2016 |
Challenges in management of complex panic disorder in a palliative care setting.
Topics: Anti-Anxiety Agents; Anxiety; Breathing Exercises; Comorbidity; Death; Dibenzothiazepines; Eye Movement Desensitization Reprocessing; Female; Humans; Hypnosis; Lung Neoplasms; Mianserin; Middle Aged; Mirtazapine; Palliative Care; Panic Disorder; Quetiapine Fumarate; Stress Disorders, Post-Traumatic; Terminal Care | 2012 |
Panic disorder and suicidal ideation.
Topics: Adult; Death; Female; Humans; Male; Panic Disorder; Phobic Disorders; Suicide | 1992 |